Innate Pharma (IPHA) Stock Chart & Stock Price History $1.88 -0.02 (-1.06%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Innate Pharma Stock Price Performance5 Day Performance+9.65%1 Month Performance-13.61%3 Month Performance-12.59%6 Month Performance-22.84%Year-To-Date Performance-33.04%1 Year Performance-15.92% Receive IPHA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. IPHA Stock Chart for Saturday, November, 2, 2024 IPHA Chart by TradingView Innate Pharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$1.89$1.88-0.85%$1.91$1.836,627 shs$151.82 million10/31/2024$1.83$1.89+3.33%$1.95$1.8014,841 shs$153.11 million10/30/2024$1.85$1.83-1.08%$1.84$1.779,178 shs$148.17 million10/29/2024$1.71$1.85+8.19%$1.86$1.812,775 shs$149.79 million10/28/2024$1.80$1.71-5.00%$1.78$1.7134,144 shs$138.46 million10/25/2024$1.85$1.80-2.45%$1.84$1.80808 shs$145.74 million Get the Latest News and Ratings for IPHA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$1.93$1.85-4.39%$1.88$1.705,116 shs$149.41 million10/23/2024$1.92$1.93+0.78%$1.93$1.795,976 shs$156.27 million10/22/2024$1.92$1.92-0.26%$1.95$1.871,968 shs$155.05 million10/21/2024$2.04$1.92-5.65%$1.98$1.8845,783 shs$155.46 million10/18/2024$2.01$1.98-1.49%$2.04$1.9425,089 shs$160.32 million10/17/2024$2.10$2.01-4.29%$2.03$1.9813,031 shs$162.74 million10/16/2024$2.03$2.10+3.45%$2.10$2.033,942 shs$170.03 million10/15/2024$2.01$2.03+1.00%$2.03$2.03960 shs$164.36 million10/14/2024$2.07$2.01-2.90%$2.05$1.9413,403 shs$162.74 million10/11/2024$1.98$2.07+4.55%$2.07$2.006,719 shs$167.61 million10/10/2024$2.11$1.98-5.94%$2.06$1.9716,582 shs$160.32 million10/09/2024$2.14$2.11-1.64%$2.11$2.034,790 shs$170.44 million10/08/2024$2.06$2.14+3.88%$2.14$2.071,289 shs$173.27 million10/07/2024$2.17$2.06-4.99%$2.14$2.0615,730 shs$166.79 million10/04/2024$2.14$2.17+1.32%$2.24$2.101,928 shs$175.56 million10/03/2024$2.17$2.14-1.40%$2.27$2.14694 shs$173.27 million10/02/2024$2.15$2.17+0.94%$2.17$2.159,060 shs$175.72 million10/01/2024$2.29$2.15-6.11%$2.24$2.1514,597 shs$174.08 million09/30/2024$2.20$2.29+4.09%$2.29$2.1724,592 shs$185.41 million09/27/2024$2.15$2.20+2.33%$2.21$2.173,034 shs$178.13 million09/26/2024$2.14$2.15+0.47%$2.23$2.1027,018 shs$174.09 million09/25/2024$2.20$2.14-2.73%$2.20$2.1225,264 shs$173.28 million09/24/2024$2.20$2.20$2.26$2.202,001 shs$178.13 million09/23/2024$2.25$2.20-2.22%$2.26$2.176,353 shs$178.13 million09/20/2024$2.25$2.25$2.25$2.25409 shs$182.18 million09/19/2024$2.25$2.25$2.25$2.214,341 shs$182.18 million09/18/2024$2.21$2.25+1.81%$2.25$2.079,828 shs$182.18 million09/17/2024$2.17$2.21+1.84%$2.29$2.128,488 shs$178.94 million09/16/2024$2.26$2.17-3.98%$2.26$2.168,502 shs$175.70 million09/13/2024$2.28$2.26-0.88%$2.35$2.2212,685 shs$182.99 million09/12/2024$2.36$2.28-3.39%$2.32$2.278,224 shs$184.61 million09/11/2024$2.38$2.36-0.84%$2.37$2.302,123 shs$191.08 million09/10/2024$2.25$2.38+5.78%$2.38$2.331,847 shs$192.70 million09/09/2024$2.31$2.25-2.60%$2.41$2.2212,907 shs$182.17 millionWe recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.09/06/2024$2.33$2.31-0.86%$2.34$2.311,695 shs$187.03 million09/05/2024$2.23$2.33+4.48%$2.33$2.31493 shs$188.65 million09/04/2024$2.23$2.23$2.35$2.147,295 shs$180.56 million09/03/2024$2.30$2.23-3.04%$2.34$2.223,791 shs$180.56 million09/02/2024$2.30$2.30+0.22%$2.40$2.252,000 shs$186.23 million08/30/2024$2.44$2.30-5.74%$2.40$2.252,022 shs$186.22 million08/29/2024$2.26$2.44+8.20%$2.44$2.128,325 shs$197.56 million08/28/2024$2.16$2.26+4.40%$2.32$2.108,197 shs$182.58 million08/27/2024$2.22$2.16-2.70%$2.31$2.166,175 shs$174.89 million08/26/2024$2.21$2.22+0.45%$2.22$2.21364 shs$179.75 million08/23/2024$2.26$2.21-2.21%$2.34$2.192,934 shs$178.94 million08/22/2024$2.26$2.26$2.33$2.1811,263 shs$182.99 million08/21/2024$2.34$2.26-3.42%$2.36$2.189,863 shs$182.99 million08/20/2024$2.33$2.34+0.44%$2.34$2.1111,230 shs$189.46 million08/19/2024$2.21$2.33+5.42%$2.33$2.2312,966 shs$188.63 million08/16/2024$2.25$2.21-1.78%$2.24$2.211,210 shs$178.94 million08/15/2024$2.19$2.25+2.74%$2.25$2.182,510 shs$182.18 million08/14/2024$2.15$2.19+1.86%$2.32$2.192,861 shs$177.32 million08/13/2024$2.21$2.15-2.71%$2.18$2.157,881 shs$174.08 million08/12/2024$2.26$2.21-2.21%$2.30$2.147,303 shs$178.94 million08/09/2024$2.26$2.26+0.04%$2.26$2.15742 shs$182.99 million08/08/2024$2.13$2.26+6.05%$2.26$2.15608 shs$182.90 million08/07/2024$2.24$2.13-4.90%$2.15$2.1313,291 shs$172.48 million08/06/2024$2.07$2.24+8.21%$2.25$2.067,439 shs$181.37 million08/05/2024$2.15$2.07-3.50%$2.09$2.065,637 shs$167.60 million08/02/2024$2.18$2.15-1.61%$2.18$2.062,557 shs$173.68 million08/01/2024$2.15$2.18+1.63%$2.20$2.164,859 shs$176.52 million Related Companies MREO Stock Price Chart EXAI Stock Price Chart ALMS Stock Price Chart ALGS Stock Price Chart AURA Stock Price Chart QTTB Stock Price Chart SLN Stock Price Chart ARCT Stock Price Chart KALV Stock Price Chart PRTC Stock Price Chart Receive IPHA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IPHA) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innate Pharma S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innate Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
